- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05697627
Cognitive Training Video Game to Target Subclinical Depressive Symptoms in Youth
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48109
- University of Michigan
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion criteria:
- Parent or guardian willing to give informed consent, and children willing to give informed assent to participate in the study.
- Males and females (age 9 - 17.99)
- Participant is willing to engage in a technology-based intervention (technology will be provided to participants who live in the state of Michigan, if not already accessible to participant).
- Self-reported depressive symptoms (Children's Depression Inventory [CDI] score between 3-19 at Assessment 1)
- Participants will be required to maintain a stable dose of medications
EXCLUSION CRITERIA
- Color blindness
- Unable to play the video game for any reason
- Current Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS) diagnosis of clinical depression, psychosis, or Autism Spectrum Disorder
- Has enrolled in new psychotherapy (for the treatment of a mood or anxiety disorder) or had changes to their psychotherapy in the 4-weeks prior to study enrollment
- Endorses items #1, #2, #3, #4, #5, or #6 on the Columbia Suicide Severity Rating Scale (C-SSRS) Screener (Past-Month); i.e., has present suicidal intention/behavior.
- Has had any changes to their medication in the 4-weeks prior to study enrollment
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Computerized cognitive training (CCT) using EndeavorRx
Exciting, youth-friendly computer game, EndeavorRx engages and trains cognitive control across component processes of attention, response inhibition, shifting and working memory.
|
The EndeavorRx video game is a digital therapeutic designed to improve attention and related cognitive control processes by training interference management. ~25 minutes of EndeavorRx video game play per day, for 5 days/week, for up to 4 weeks |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Depressive Symptoms as Measured by Children's Depression Inventory (CDI)
Time Frame: Baseline and approximately 5 weeks after
|
The CDI was a self-report, 27 item scale used to measure depressive symptoms.
Total scores on the CDI ranged from 0 (no depressive symptoms) to 54 (extremely severe depressive symptoms).
Higher scores indicated worse depressive symptoms.
CDI scores were collected from participants at three timepoints: 1) baseline, 2) approximately 5 weeks after baseline, and 3) up to 4 months after baseline.
Results reflect CDI scores collected at the first and second timepoints.
|
Baseline and approximately 5 weeks after
|
|
Change in Depressive Symptoms as Measured by Children's Depression Rating Scale - Revised (CDRS-R)
Time Frame: Baseline and approximately 5 weeks after
|
The CDRS-R is a clinician-administered tool used to assess the severity of depression in children and adolescents based on a 17-item scale of depressive symptoms.
Total raw scores on this scale range from 17-113, with 17 indicating no or minimal depressive symptoms and 113 indicating extremely severe symptoms of depression.
CDRS-R scores were collected from participants at three timepoints: 1) baseline, 2) approximately 5 weeks after baseline, and 3) up to 4 months after baseline.
Results reflect CDRS-R scores collected at the first and second timepoints.
|
Baseline and approximately 5 weeks after
|
|
Change in Cognitive Control Capacity - Overall Reaction Time (RT) Stroop
Time Frame: Baseline and approximately 5 weeks after
|
The Stroop task assesses cognitive control and emotion regulation over emotional information processing by measuring how quickly individuals name the ink color of words that are emotionally-charged or neutral.
For this measure, lower scores indicated better performance, i.e., better cognitive control and emotion regulation.
Results reflect the average reaction time across all trials of the Stroop task that participants completed.
|
Baseline and approximately 5 weeks after
|
|
Change in Cognitive Control Capacity - Conflict RT Stroop
Time Frame: Baseline and approximately 5 weeks after
|
The Stroop task assesses cognitive control and emotion regulation over emotional information processing by measuring how quickly individuals name the ink color of words that are emotionally-charged or neutral.
For this measure, lower scores indicated better performance, i.e., better cognitive control and emotion regulation.
Results reflect the difference in the reaction time between incongruent trials and congruent trials on the Stroop task.
|
Baseline and approximately 5 weeks after
|
|
Change in Cognitive Control Capacity - Overall RT Flanker
Time Frame: Baseline and approximately 5 weeks after
|
The Flanker task is a psychological experiment that assesses a person's ability to focus on a target stimulus while ignoring distracting stimuli.
For this measure, higher scores indicate better performance.
Results reflect the average reaction time across all trials of the Flanker task that participants completed at this timepoint.
|
Baseline and approximately 5 weeks after
|
|
Change in Cognitive Control Capacity - Conflict RT Flanker
Time Frame: Baseline and approximately 5 weeks after
|
The Flanker task is a psychological experiment that assesses a person's ability to focus on a target stimulus while ignoring distracting stimuli.
For this measure, higher scores indicate better performance.
Results reflect the difference in the reaction time between incongruent trials and congruent trials of the Flanker task.
|
Baseline and approximately 5 weeks after
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Children's Depression Inventory (CDI) at Third Timepoint
Time Frame: Up to 4 months
|
The CDI was a self-report, 27 item scale used to measure depressive symptoms.
Total scores on the CDI ranged from 0 (no depressive symptoms) to 54 (extremely severe depressive symptoms).
Higher scores indicated worse depressive symptoms.
CDI scores were collected from participants at three timepoints: 1) baseline, 2) approximately 5 weeks after baseline, and 3) up to 4 months after baseline.
Results reflect CDI scores collected at the third timepoint.
|
Up to 4 months
|
|
Depressive Symptoms as Measured by Children's Depression Rating Scale - Revised (CDRS-R) at Third Timepoint
Time Frame: Up to 4 months
|
The CDRS-R is a clinician-administered tool used to assess the severity of depression in children and adolescents based on a 17-item scale of depressive symptoms.
Total raw scores on this scale range from 17-113, with 17 indicating no or minimal depressive symptoms and 113 indicating extremely severe symptoms of depression.
CDRS-R scores were collected from participants at three timepoints: 1) baseline, 2) approximately 5 weeks after baseline, and 3) up to 4 months after baseline.
Results reflect CDRS-R scores collected at the third timepoint.
|
Up to 4 months
|
|
Cognitive Control Capacity - Overall Reaction Time (RT) Stroop
Time Frame: Up to 4 months
|
The Stroop task assesses cognitive control and emotion regulation over emotional information processing by measuring how quickly individuals name the ink color of words that are emotionally-charged or neutral.
For this measure, lower scores indicated better performance, i.e., better cognitive control and emotion regulation.
Results reflect the average reaction time across all trials of the Stroop task that participants completed at this timepoint.
|
Up to 4 months
|
|
Cognitive Control Capacity - Conflict RT Stroop
Time Frame: Up to 4 months
|
The Stroop task assesses cognitive control and emotion regulation over emotional information processing by measuring how quickly individuals name the ink color of words that are emotionally-charged or neutral.
For this measure, lower scores indicated better performance, i.e., better cognitive control and emotion regulation.
Results reflect the difference in the reaction time between incongruent trials and congruent trials on the Stroop task.
|
Up to 4 months
|
|
Cognitive Control Capacity - Overall RT Flanker
Time Frame: Up to 4 months
|
The Flanker task is a psychological experiment that assesses a person's ability to focus on a target stimulus while ignoring distracting stimuli.
For this measure, higher scores indicate better performance.
Results reflect the average reaction time across all trials of the Flanker task that participants completed at this timepoint.
|
Up to 4 months
|
|
Cognitive Control Capacity - Conflict RT Flanker
Time Frame: Up to 4 months
|
The Flanker task is a psychological experiment that assesses a person's ability to focus on a target stimulus while ignoring distracting stimuli.
For this measure, higher scores indicate better performance.
Results reflect the difference in the reaction time between incongruent trials and congruent trials on the Flanker task.
|
Up to 4 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility/Acceptability and Experimental Outcome
Time Frame: Up to 4 months
|
Outcome measures that indicate how much the video game was played and acceptability of the game as indicated by self-report ratings. Includes: gameplay metrics from the video game (total amount of missions completed across the 4-weeks of the intervention), Endeavor Satisfaction Survey Scores (Scale 1-5 (3 is neutral) on each item; parent and child report), and depressive symptoms at baseline (Children's Depression Inventory). |
Up to 4 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Hannah Becker, M.S., University of Michigan
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HUM00227345
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.